Prevalence of parvovirus B19 infection in Thai young adults.

The prevalence of antibody to human parvovirus B19 in 128 Thai healthy young adults was measured. Antibodies of the immunoglobulin G (IgG) class were investigated in serum samples of 51 males and 77 females aged 18-24 years (mean 19.83; SD 1.07) by a commercial enzyme-linked immunosorbent assay (ELISA) using high specific recombinant parvovirus B 19 antigen. Only 14 out of 128 (10.94%) sera were found positive, including 6 males and 8 females. No sex preponderance was observed. The amount of antibody calculated as antibody index was not statistically significant difference between genders.

[1]  K. Brown,et al.  Human Parvovirus B19 , 2002, Clinical Microbiology Reviews.

[2]  U. Thisyakorn,et al.  Seroprevalence of Epstein-Barr virus infection in Thai children. , 2001, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[3]  P. Bhattarakosol,et al.  Seroprevalence of anti-human herpes virus-6 IgG antibody in children of Bangkok, Thailand. , 2001, The Southeast Asian journal of tropical medicine and public health.

[4]  A. Theamboonlers,et al.  Parvovirus B19 antibodies in immunocompromized children in Thailand. , 2000, Asian Pacific journal of allergy and immunology.

[5]  A. Theamboonlers,et al.  Prevalence of antibodies to parvovirus B 19 in Thailand. , 2000, The Southeast Asian journal of tropical medicine and public health.

[6]  Chien-Jen Chen,et al.  Seroepidemiology of human parvovirus B19 in Taiwan , 1999, Journal of medical virology.

[7]  K. Sugamura,et al.  The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. , 1998, The Journal of infection.

[8]  U. Thisyakorn,et al.  Seroprevalence of cytomegalovirus infection in children. , 1998, The Southeast Asian journal of tropical medicine and public health.

[9]  M. Mata Rebón,et al.  [Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia]. , 1998, Enfermedades infecciosas y microbiologia clinica.

[10]  J. Samal,et al.  [Parvovirus B19 in the Czech Republic. Seroepidemiologic study]. , 1997, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne.

[11]  A. Pacsa,et al.  Seroprevalence of human parvovirus B19 in children of a desert region. , 1996, Annals of tropical paediatrics.

[12]  H. Sato,et al.  Human Parvovirus B19 Infection in Blood Donors , 1995, Vox sanguinis.

[13]  K. Goh,et al.  Low prevalence of antibody to human parvovirus B19 in Singapore , 1994, Epidemiology and Infection.

[14]  K. Zakrzewska,et al.  Human parvovirus B19 infection in bone marrow transplantation patients , 1993, American journal of hematology.

[15]  B. Cohen,et al.  The prevalence of antibody to human parvovirus B19 in England and Wales. , 1988, Journal of medical microbiology.

[16]  R. Holman,et al.  The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). , 1986, The Journal of infectious diseases.

[17]  M. Anderson,et al.  Experimental parvoviral infection in humans. , 1985, The Journal of infectious diseases.

[18]  M. Anderson,et al.  An outbreak of erythema infectiosum associated with human parvovirus infection , 1984, Journal of Hygiene.

[19]  M. Anderson,et al.  Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. , 1982, Journal of clinical pathology.

[20]  E. Caul,et al.  PARVOVIRUS-LIKE PARTICLES IN HUMAN SERA , 1975, The Lancet.